Featured
Last news
Organto Foods Inc. Announces Prepayment of Convertible Notes
Optimizes Capital Structure and Financial Flexibility
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.
Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025
TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20, 2025.
Ex-abbot of China's Shaolin Temple arrested for embezzlement
The former head of the Chinese temple known as the birthplace of kung fu has been arrested over suspicion of embezzlement, local authorities said Sunday.
President Trumps Cannabis Decision Soon: From Hemp Shutdown to Pharmaceutical Clarity: MMJ Leads Federally Legal Cannabis Drug Development
"The federal hemp crackdown has created long overdue pharmaceutical clarity. MMJ is now the company advancing a fully compliant cannabinoid drug program under FDA and DEA oversight," noted Duane Boise, CEO MMJ International Holdings. "Drug development allows for no shortcuts. It demands consistency, validation, and adherence to federal law."
Doha Tattoo Festival Announced as Ticket Sales Officially Open
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village.
Huge fire sparked by explosions near Argentine capital 'contained'
A large blaze ignited by powerful explosions at an industrial park near Argentina's capital has been contained, local authorities reported on Saturday.
Huge explosions rock industrial area near Argentina's capital
Powerful explosions tore through an industrial park near Argentina's capital on Friday, sparking a huge blaze and injuring more than 20 people.
Nine killed in accidental explosion at Indian Kashmir police station
Nine people were killed and 31 injured when confiscated explosives accidentally blew up at a police station in Indian-administered Kashmir, police said Saturday, just days after a car blast in Delhi killed a dozen people.
EU bows to pressure on loosening AI, privacy rules
The European Union is set next week to kickstart a rollback of landmark rules on artificial intelligence and data protection that face powerful pushback on both sides of the Atlantic.
Purdue Pharma to be dissolved as US judge says to approve bankruptcy
OxyContin maker Purdue Pharma, blamed for helping to fuel a deadly opioid crisis, said Friday that a US bankruptcy judge will sign off on a deal to settle thousands of lawsuits against the company, which will cease to exist.
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
Featured companies include Lionscrest Advisors, DataVault AI (NASDAQ:DVLT), Pudgy Penguins (PENGU)), Peer To Peer Network (OTC:PTOP), and Acurx Pharmaceuticals (NASDAQ:ACXP).
Trump demands probe into Epstein links to Bill Clinton
US President Donald Trump said Friday he wants the Justice Department and FBI to investigate links between the late alleged sex trafficker Jeffrey Epstein and former Democratic president Bill Clinton.
UN rights council orders probe of atrocities in Sudan's El-Fasher
The UN Human Rights Council on Friday ordered investigators to probe alleged atrocities in Sudan's El-Fasher and to seek to identify perpetrators so they can be brought to justice.
Thais navigate flooded homes and ancient temples by boat
For three months, Thai retiree Somkid Kijniyom has been sleeping in a small boat surviving on dry food handouts in the waist-high floodwaters that have filled his home.
Second brother of French anti-drugs activist murdered: prosecutor
A gunman on a motorbike has shot dead the 20-year-old youngest brother of a prominent anti-drug activist in the southern French city of Marseille in a possible warning over his campaigning, a prosecutor said on Friday.
BHP liable for 2015 Brazil mine disaster: UK court
A British court ruled Friday that Australian mining giant BHP is liable for one of Brazil's worst environmental disasters, potentially paving the way for billions of pounds in compensation.
What we know about deadly Delhi car blast
India has vowed to bring to justice the "perpetrators, their collaborators, and their sponsors" behind the deadliest explosion in the nation's capital for more than a decade.
Peru's interim president embraces the spotlight in 'war' on crime
Like a veritable action hero, Peru's interim president rolls up his sleeves to take part in nighttime raids on prisons and in the street, always making sure his bravado is captured on camera.
Penang's Cultural Horizon Expands with the Launch of the Lin Xiang Xiong Art Gallery
KUALA LUMPUR, MY / ACCESS Newswire / November 14, 2025 / In a defining moment for Malaysia's creative and cultural landscape, His Excellency the Governor of Penang, Tun Dato' Seri DiRaja Ramli Ngah Talib, and The Right Honourable Chief Minister of Penang, Chow Kon Yeow, officiated the opening ceremony of the Lin Xiang Xiong Art Gallery this morning at The Light Waterfront, Gelugor.
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing
Tivic Reports Third Quarter 2025 Financial Results
Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline
ADM Tronics Reports Second Quarter of Fiscal Year 2026 Results
NORTHVALE, NJ / ACCESS Newswire / November 14, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2025 of Fiscal Year 2026.
Ensysce Biosciences Reports Third Quarter 2025 Financial Results
~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~~ Further Program Advancement Supported by Preferred Stock Financing ~
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today reported business and financial results for the quarter ended September 30, 2025 (the "third quarter").
Noble Roman's Announces Significant Third Quarter Earnings Growth and Other Company Highlights
INDIANAPOLIS, IN / ACCESS Newswire / November 14, 2025 / Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, today announced third quarter 2025 financial data, other recent company highlights, and details for a conference call to be held on Monday, November 17th at 4 PM ET.
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
- Dermata announced a strategic pivot to develop and commercialize over-the-counter (OTC) skin care treatments -- Dermata plans to launch its first OTC product, a once weekly acne kit with its Spongilla technology, in the middle of 2026 -
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Shareholders approve all EGM proposals related to the combination with NeuroXBusiness combination expected to close in December 2025Relief to be renamed MindMaze Therapeutics Holding SA upon closingNew board and executive committee members announcedCompanies to host joint press conference on November 25, 2025
Luvu Brands Announces First Quarter Fiscal 2026 Results and Operational Highlights
ATLANTA, GA / ACCESS Newswire / November 14, 2025 / Luvu Brands, Inc. (OTCQB:LUVU), a vertically integrated designer, manufacturer, and marketer of consumer lifestyle brands, today reported financial and operational results for the first quarter of fiscal 2026, ended September 30, 2025.
Tom Brady 1/1 NFL Shield Autograph Card Hits Fanatics Collect Premier Auction Through Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Infinite Auctions
With 6-figure expectations this one of one 2009 Topps Unique Tom Brady card featuring a game-worn NFL Equipment patch and autograph is now live at Fanatics Collect's Premier Auction that ends Thursday, November 20, 2025 at 9:30 PM Eastern Time (EST).
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet food options. Led by Jenny L. Mace, Alexander Bauer, Andrew Knight and Billy Nicholles, the research sheds new light on the potential for alternative proteins and plant-based diets in the companion animal sector.
Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians
Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy Network') and telehealth partners mitigate patient muscle loss in the GLP-1 drug market, estimated to grow to $150 billion by 2030Company to offer first SARS-CoV-2 related natural antiviral combo for Long COVID with addition of 3CL protease inhibitor supplement Tollovid® to Galectovid 1 & 3 inhibitor Medical Food Galectovid® distribution agreement to Pharmacy Network & physicians